Treatment of Primary Infected Juxtarenal Aortic Aneurysm With the Multilayer Stent. (October 2013)

• Record Type: Journal Article
• Authors: Flis, Vojko; Matela, Jože; Breznik, Silva; Kobilica, Nina
• Is Part Of: Vascular & endovascular surgery. Volume 47:Number 7(2013)
• Page Start: 561
• Page End: 565
• Publication Date: 2013-10
• Subjects: primary infected abdominal aortic aneurysm -- juxtarenal aneurysm -- stent -- multilayer stent -- visceral artery perfusion -- sac diameter reduction; Blood-vessels -- Surgery -- Periodicals; Blood-vessels -- Endoscopic surgery -- Periodicals; Vascular Surgical Procedures -- Periodicals; Angioplasty -- Periodicals; Surgical Procedures, Minimally Invasive -- Periodicals; Vascular Diseases -- surgery -- Periodicals; Vaisseaux sanguins -- Chirurgie -- Périodiques; Vaisseaux sanguins -- Chirurgie endoscopique -- Périodiques; 617.41
• DOI: 10.1177/1538574413497108
• Languages: English
• ISSNs: 1538-5744

Abstract

Purpose: To report the use of multilayer uncovered stent to treat primary infected juxtarenal aortic aneurysm. Case Report: A 50-year-old man was admitted to hospital for rapid onset of intractable abdominal pain and high fever. Computed tomographic scan showed 2 juxtarenal saccular aneurysms of abdominal aorta with morphologic and clinical changes compatible with infectious etiology. Patient was treated with multilayer flow-modulating stent. Follow-up imaging showed persistent aneurysm exclusion and continuous aneurysm shrinkage of the sac until complete regression to a normal aortic configuration was seen at 1 year. During follow-up (24 months), patient continued to do well, and there was no recurrence of infection. Conclusion: Multilayer stent appeared to be an acceptable treatment option for primary infected juxtarenal aortic aneurysms. Aneurysmal sac completely disappeared and visceral branches remained patent at 2-year follow-up. However, longer follow-up is necessary to evaluate the long-term patency of involved visceral arteries.